November 8, 2020
NatGlycan is pleased to announce that Dr. Richard D. Cummings has joined the company as its Chief Strategic Advisor. In this role, Dr. Cummings will help NatGlycan in developing new product strategies and corporate collaborations to maximize the opportunities for applications of NatGlycan’s growing expertise in purifying and characterizing glycans for applications in functional glycomics. Dr. Cummings is the Director of the National Center for Functional Glycomics and Professor in the Department of Surgery at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston.
November 6, 2020
NatGlycan plans to attend the 2020 Virtual Society for Glycobiology Meetings on line and is a proud Silver Sponsor of the meeting. Dave Smith, acting CEO, Janice Kimpel, Chief Busines Officer, and Xeuzhang Song, Chief Scientific Officer, will be available November 9-11 in the “virtual booth” to answer your questions regarding our progress in manufacturing biologically relevant glycans and substrates for ENGase-catalyzed transglycosylation (see Technical Report No.1).
October 9, 2020